These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 9952042

  • 1. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 2. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar 25; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 4. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.
    Psychopharmacology (Berl); 2000 Jun 25; 150(2):132-40. PubMed ID: 10907666
    [Abstract] [Full Text] [Related]

  • 5. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul 25; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 6. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S, Mager T, Rossmüller B, Meisenzahl E, Hahn K, Möller HJ, Tatsch K.
    Eur J Nucl Med; 1999 Aug 25; 26(8):862-8. PubMed ID: 10436199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F, Soucy JP, Stip E, Lévesque M, Elie A, Bédard MA.
    J Neuropsychiatry Clin Neurosci; 2004 Aug 25; 16(1):47-56. PubMed ID: 14990759
    [Abstract] [Full Text] [Related]

  • 12. Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
    Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmüller B, Frodl T, Preuss UW, Hahn K, Möller HJ.
    J Psychopharmacol; 2002 Sep 25; 16(3):200-6. PubMed ID: 12236625
    [Abstract] [Full Text] [Related]

  • 13. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb 25; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 14. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.
    Kasper S, Tauscher J, Küfferle B, Barnas C, Hesselmann B, Asenbaum S, Podreka I, Brücke T.
    Psychopharmacology (Berl); 1998 Apr 25; 136(4):367-73. PubMed ID: 9600582
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.
    Psychiatry Clin Neurosci; 2009 Aug 25; 63(4):529-37. PubMed ID: 19496999
    [Abstract] [Full Text] [Related]

  • 16. D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
    Meisenzahl EM, Dresel S, Frodl T, Schmitt GJ, Preuss UW, Rossmüller B, Tatsch K, Mager T, Hahn K, Möller HJ.
    J Psychopharmacol; 2000 Aug 25; 14(4):364-70. PubMed ID: 11198054
    [Abstract] [Full Text] [Related]

  • 17. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K.
    Psychopharmacology (Berl); 1996 Apr 25; 124(3):285-7. PubMed ID: 8740053
    [Abstract] [Full Text] [Related]

  • 18. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J.
    Am J Psychiatry; 1996 Dec 25; 153(12):1571-8. PubMed ID: 8942453
    [Abstract] [Full Text] [Related]

  • 19. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 25; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 20. Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.
    Nordström AL, Nyberg S, Olsson H, Farde L.
    Arch Gen Psychiatry; 1998 Mar 25; 55(3):283-4. PubMed ID: 9510228
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.